June. 27, 2019 |
|
Nov. 02, 2023 |
|
jRCTs051190030 |
Randomized, placebo-controlled phase II study of efficacy of morphine for dyspnea in patients with interstitial lung disease: JORTC-PAL15 |
|
Randomized, placebo-controlled phase II study of efficacy of morphine for dyspnea in patients with interstitial lung disease: JORTC-PAL15 |
Matsuda Yoshinobu |
||
National Hospital Organization Kinki-Chuo Chest Medical Center |
||
Nagasone-Cho 1180, Kita-Ku, Sakai City, Osaka |
||
+81-72-252-3021 |
||
matsuda.yoshinobu.tx@mail.hosp.go.jp |
||
Matsuda Yoshinobu |
||
National Hospital Organization Kinki-Chuo Chest Medical Center |
||
Nagasone-cho 1180, Kita-ku, Sakai city, Osaka |
||
+81-72-252-3021 |
||
matsuda.yoshinobu.tx@mail.hosp.go.jp |
Recruiting |
June. 27, 2019 |
||
Sept. 05, 2019 | ||
50 | ||
Interventional |
||
randomized controlled trial |
||
single blind |
||
placebo control |
||
parallel assignment |
||
treatment purpose |
||
1. Patients who are diagnosed with ILD by two respiratory physicians and one respiratory radiologist |
||
1. Patients who have contraindication for morphine |
||
20age old over | ||
No limit | ||
Both |
||
Interstitial lung disease |
||
Morphine arm: single subcutaneous morphine 2 mg |
||
Interstitial lung disease |
||
morphine |
||
Lung Diseases, Interstitial |
||
morphine |
||
Difference of change of dyspnea at rest in NRS from baseline to 60 minutes after morphine injection between morphine arm and placebo arm |
||
1. Change of dyspnea at rest in NRS from baseline to 30 minutes after morphine or placebo injection |
Grants-in-aid for Young Scientists (A) | |
Not applicable |
The Osaka Medical Research Foundation for Intractable Diseases. | |
Not applicable |
Osaka Metropolitan University Hospital Certified Review Board | |
1-2-7-601, Asahimachi, Abeno-ku Osaka-shi, Osaka, 545-0051, Japan, Osaka | |
+81-6-6645-3456 |
|
gr-a-knky-crb@omu.ac.jp | |
Approval | |
Mar. 22, 2019 |
Yes |
|
Immediately after the publication of the primary results, de-identified individual participant data that underlie the results reported in the article(s) and other documents (study protocol and statistical analysis plan) will be available for any purpose, only if approved by JORTC Independent Data Monitoring Committee (IDMC). Anyone who wishes to access the data should submit a proposal to office@idmc.jortc.jp. If approved, data requestors will need to sign a data access agreement. After that, JORTC Data Center will transfer the data and other documents to data requestors. |
none |